Author:
OONO Takashi,SEGAWA Makoto,HASHIMOTO Shinichi,UCHIDA Koichi,TERAI Shuji,YAMASAKI Takahiro,HOSHII Yoshinobu,SAKAIDA Isao
Publisher
Yamaguchi University Medical Association
Reference21 articles.
1. One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
2. Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
3. The pilot study: a novel transarterial chemoembolization using degradable starch microspheres for hepatocellular carcinoma
4. 4) Yamasaki T, Hamabe S, Saeki I, et al. A novel transarterial infusion chemotherapy using iodized oil and degradable starch microspheres for hepatocellular carcinoma: a prospective randomized trial. J Gastroenterol 2011; 46: 359-366.
5. 5) Bosman FT, Carneiro F, Theise ND. Nomenclature and classification of neuroendocrine neoplasms of digestive system. WHO classification of tumors of the digestive system 4th> Ed., IARC, Lyon, 2010; 13-14.